Bio-Rad Laboratories BIO
NYSE BIO
$366.15 -4.35 (-1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Bio-Rad Laboratories (BIO) Non-Current Deferred Revenue (2015 - 2016)

Updated

Bio-Rad Laboratories (BIO) posted Non-Current Deferred Revenue of $4.4 million for Q3 2016.

Analysis

Bio-Rad Laboratories (BIO) Non-Current Deferred Revenue (2015 - 2016) Analysis & Trends

At the end of FY2015, Bio-Rad Laboratories' Non-Current Deferred Revenue came in at $3.74 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Bio-Rad Laboratories 9.85 Bn 3.46 Bn 328.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 4.40 Mn
Dec 31, 2015 3.74 Mn
API Access

Bio-Rad Laboratories Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BIO&period=max&api_key=YOUR_API_KEY